Paycom Software, Inc. (PAYC) earnings date, results and what the price requires
NYSE · SEC CIK 0001590955 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $531.2M | $107.4M | $2.34 | Filing |
| Mar 31, 2026 | May 6, 2026 | $571.9M | $155.7M | $3.04 | Filing |
| Dec 31, 2025 | Feb 11, 2026 | $544.3M | $113.8M | $2.06 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $493.3M | $110.7M | $1.96 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $483.6M | $89.5M | $1.58 | Filing |
| Mar 31, 2025 | May 7, 2025 | $530.5M | $139.4M | $2.48 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $493.9M | $113.5M | $2.04 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $451.9M | $73.3M | $1.31 | Filing |
What would Paycom Software, Inc. have to report for its valuation to change?
At $251.64, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 18.0% a year, to $21.51. On that path the next quarter needs diluted EPS near $2.31, against $1.96 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 18.0% | 18.0% |
| EPS needed in final year | $21.51 | $21.51 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. PAYC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.